Platelet-rich plasma ameliorates lipopolysaccharide-induced cardiac injury by inflammation and ferroptosis regulation
Sepsis-induced myocardial dysfunction (SIMD) is a fatal disease with no specific treatment worldwide to this day. As a biological product, platelet-rich plasma (PRP) has attracted much attention due to its diverse and potential biological effects. However, its role in lipopolysaccharide (LPS)-induce...
Main Authors: | Yuheng Jiao, Qingyu Zhang, Jiayan Zhang, Yafang Zha, Jian Wang, Yanyan Li, Song Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1026641/full |
Similar Items
-
Platelet yield and yield consistency for six single-spin methods of platelet rich plasma preparation
by: Theodore E. Harrison, et al.
Published: (2020-07-01) -
A review of platelet-rich fibrin and its application in the treatment of diseases
by: Naser Kalhorqom, et al.
Published: (2019-08-01) -
3,4-Dihydroxyphenylethanol ameliorates lipopolysaccharide-induced septic cardiac injury in a murine model
by: Zhang Lu, et al.
Published: (2021-12-01) -
Platelet-rich preparations as biocarriers for local drugs for periodontal disease: A narrative review
by: Esra Ercan, et al.
Published: (2023-01-01) -
An introduction to application of platelet rich plasma (PRP) in skin rejuvenation
by: Mahnaz Banihashemi, et al.
Published: (2014-04-01)